NO20030978D0 - Behandling av diuresedysfunksjon - Google Patents

Behandling av diuresedysfunksjon

Info

Publication number
NO20030978D0
NO20030978D0 NO20030978A NO20030978A NO20030978D0 NO 20030978 D0 NO20030978 D0 NO 20030978D0 NO 20030978 A NO20030978 A NO 20030978A NO 20030978 A NO20030978 A NO 20030978A NO 20030978 D0 NO20030978 D0 NO 20030978D0
Authority
NO
Norway
Prior art keywords
diuresis
dysfunction
treatment
diuresis dysfunction
Prior art date
Application number
NO20030978A
Other languages
English (en)
Other versions
NO20030978L (no
Inventor
Julian Alexander Barden
Angus Gidley-Baird
Original Assignee
Intreat Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreat Pty Ltd filed Critical Intreat Pty Ltd
Publication of NO20030978D0 publication Critical patent/NO20030978D0/no
Publication of NO20030978L publication Critical patent/NO20030978L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20030978A 2000-08-28 2003-02-28 Behandling av urindysfunksjon NO20030978L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ9687A AUPQ968700A0 (en) 2000-08-28 2000-08-28 Treatment of urinary incontinence
PCT/AU2001/001079 WO2002017929A1 (en) 2000-08-28 2001-08-28 Treatment of urinary dysfunction

Publications (2)

Publication Number Publication Date
NO20030978D0 true NO20030978D0 (no) 2003-02-28
NO20030978L NO20030978L (no) 2003-04-16

Family

ID=3823741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030978A NO20030978L (no) 2000-08-28 2003-02-28 Behandling av urindysfunksjon

Country Status (19)

Country Link
US (1) US20040067967A1 (no)
EP (1) EP1315503A4 (no)
JP (1) JP2004506744A (no)
KR (1) KR20030034162A (no)
CN (2) CN101164541A (no)
AU (1) AUPQ968700A0 (no)
BR (1) BR0113667A (no)
CA (1) CA2420846A1 (no)
CZ (1) CZ2003807A3 (no)
EA (1) EA007092B1 (no)
EE (1) EE200300082A (no)
HU (1) HUP0300860A3 (no)
IL (1) IL154642A0 (no)
MX (1) MXPA03001833A (no)
NO (1) NO20030978L (no)
NZ (1) NZ537643A (no)
PL (1) PL360368A1 (no)
WO (1) WO2002017929A1 (no)
ZA (1) ZA200302340B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514940A (ja) * 2002-01-18 2005-05-26 ミレニアム・ファーマシューティカルズ・インコーポレイテッド １４３５分子、５５９分子、３４０２１分子、４４０９９分子、２５２７８分子、６４１分子、２６０分子、５５０８９分子、２１４０７分子、４２０３２分子、４６６５６分子、６２５５３分子、３０２分子、３２３分子、１２３０３分子、９８５分子、１３２３７分子、１３６０１分子、１８９２６分子、３１８分子、２０５８分子または６３５１分子を用いる泌尿器疾患を処置するための方法および組成物
US20050143323A1 (en) * 2003-12-30 2005-06-30 Henley E. C. Isoflavone therapy for treating urinary incontinence
KR100462173B1 (ko) * 2004-06-08 2004-12-16 안국약품 주식회사 요실금 예방 및 치료용 조성물
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
WO2007020194A1 (en) * 2005-08-15 2007-02-22 F. Hoffmann-La Roche Ag Piperidine and piperazine derivatives as p2x3 antagonists
JP5193196B2 (ja) 2006-06-02 2013-05-08 ペア ツリー ウーマンズ ヘルス ケア 萎縮性膣炎の治療の方法
DK2343281T3 (en) * 2006-10-04 2014-03-24 Hoffmann La Roche Process for the Synthesis of Phenoxydiamino-Pyrimidine Derivatives
US8277426B2 (en) 2009-09-30 2012-10-02 Wilcox Heather J Male urinary incontinence device
CN109862883A (zh) 2016-10-21 2019-06-07 生物权威（英国）有限公司 细胞毒性颗粒
WO2021065027A1 (ja) * 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
MX2022003983A (es) * 2019-10-02 2022-04-26 Aska Pharm Co Ltd Agente mejorador de los trastornos de la miccion.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2566595A (en) * 1994-05-27 1995-12-21 Glaxo Group Limited P-2x receptors (purinoceptor family)
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5856129A (en) * 1996-10-30 1999-01-05 Incyte Pharmaceuticals, Inc. DNA encoding a human purinoceptor

Also Published As

Publication number Publication date
CA2420846A1 (en) 2002-03-07
KR20030034162A (ko) 2003-05-01
HUP0300860A2 (hu) 2003-11-28
IL154642A0 (en) 2003-09-17
EA007092B1 (ru) 2006-06-30
CN101164541A (zh) 2008-04-23
BR0113667A (pt) 2003-06-03
ZA200302340B (en) 2004-06-28
PL360368A1 (en) 2004-09-06
EE200300082A (et) 2004-12-15
CZ2003807A3 (cs) 2003-08-13
EA200300264A1 (ru) 2003-10-30
EP1315503A4 (en) 2005-02-09
US20040067967A1 (en) 2004-04-08
MXPA03001833A (es) 2004-11-01
HUP0300860A3 (en) 2005-03-29
JP2004506744A (ja) 2004-03-04
WO2002017929A1 (en) 2002-03-07
EP1315503A1 (en) 2003-06-04
NZ537643A (en) 2006-04-28
CN1479621A (zh) 2004-03-03
AUPQ968700A0 (en) 2000-09-21
NO20030978L (no) 2003-04-16

Similar Documents

Publication Publication Date Title
NO20003845L (no) Behandling av kvinnelig seksuell dysfunksjon
ID30590A (id) Celana sekali pakai jenis-celana pendek
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
ID30187A (id) Dongkrak jenis pantagraf
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20024442L (no) Behandling av seksuell dysfunksjon med apomorfin
NO20030978D0 (no) Behandling av diuresedysfunksjon
NO20041968L (no) Anvendelse av cystationin
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
NO20024236D0 (no) Behandling av psoriasis
DE60103685D1 (de) Behandlung von Poriomania
DE60031450D1 (de) Polymorph v von torasemid
NO20004513D0 (no) Oksygenering av sjøvann
PL362980A1 (en) Treatment of sexual dysfunction
DE60007360D1 (de) Amorphe modifikation von torasemid
NO20031953D0 (no) Anvendelse av disazoforbindelser
NO20022101D0 (no) Peptider for behandling av erektil dysfunksjon
ID30381A (id) Penggunaan arilalkanoilpiridazina
SE0300535L (sv) Behandling av brännskador
NO20025765D0 (no) Kombinasjonssett for behandling av malaria
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
UA4353S (uk) Масажне кільце

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application